Share Price:

APNASPENAspen Pharmacare Hldgs971825 (0.26%)

Key ARV Products Vireadยฎ and Truvadaยฎ Registered by MCC

JSE listed Aspen, a leading global manufacturer and distributor of anti-retroviral (ARV) medicines, today announced that it has been granted certification from the Medicines Control Council of South Africa (MCC) to manufacture and distribute the two key ARV products Vireadยฎ (tenofovir disoproxil fumarate) and Truvadaยฎ (emtricitabine and tenofovir disoproxil fumarate) in the South African market.… Continue reading Key ARV Products Vireadยฎ and Truvadaยฎ Registered by MCC

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.